Pharmacological Solutions by unknown
99
Introduction
In a lengthy and  well- cited article published in the Journal of the Royal 
College of General Practitioners in 1971, Peter Parish, physician and medi-
cal sociologist at University College Swansea, stated that as a result of 
advances in psychopharmacology and the influences of advertising, 
‘large sections both of the medical profession and the general public 
have come to regard psychotropic drugs as a universal panacea for a 
wide range of social and emotional problems’.1 The resulting cost to the 
NHS was considerable. As Parish pointed out, between 1965 and 1970, 
47.2 million psychotropic drug prescriptions were dispensed under the 
National Health Service (NHS), costing a sizeable £21.5 million.2 The 
soaring cost of psychotropic drugs prompted much debate in the medi-
cal press about their use and efficacy. Interest was particularly focused 
on prescribing patterns between individual doctors and between prac-
tices across the country  – and on how doctors gained information 
about indications for different drugs. Additionally, there were heated 
debates about the efficacy of different groups of drugs. Although there 
was much confusion and disagreement on these topics, research articles 
nonetheless reflected one consistent finding: at least twice as many pre-
scriptions for psychotropic drugs were issued to women than to men. 
From  mid- century, on both sides of the Atlantic, scholars and clinicians 
have attempted to account for this difference. Some have argued that, 
from the 1950s there has been an epidemic of psychological illness in 
women. Others maintain that women are simply more likely to seek 
medical advice and that doctors have tended to ‘code’ psychological dis-
orders as female problems.3 The purpose of this chapter is to consider a 
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of published research on the topic, combined with the recollections of 
retired doctors, suggests that there are many reasons why women were 
prescribed drugs more frequently and that official data on prescribing 
obscures a more complicated picture. Mental ‘distress’ in men was more 
common than has been previously acknowledged and was treated in 
different ways, often with alternative drugs and with  self- medication 
with  over- the- counter remedies.
Psychotropic drugs from the 1950s
The  post- war period was central to developments in the pharmacologi-
cal treatment of mental illness and much has been written about the 
evolution of new treatments from the 1950s. Numerous historians of 
psychiatry, pharmacology and mental illness have published accounts 
of their emergence. It is not the remit of this chapter to repeat such 
histories in detail; however, certain aspects of these developments 
deserve highlighting. During the period covered by this book, the 
chemotherapeutic treatment of anxiety disorders, for example, changed 
significantly with the shift in popularity from  old- style hypnotic seda-
tive drugs to the newer tranquillising agents during the 1960s. As has 
been pointed out already, during the period, depression was also more 
commonly identified as a condition in its own right, treated specifically 
with new antidepressants. This chapter will explore debates about the 
use of these drugs and examine prescribing patterns between doctors.
As is well known, the late 1950s were characterised by cautious opti-
mism surrounding the discovery of the therapeutic effects of the major 
tranquilliser, chlorpromazine, for the treatment of serious psychosis.4 
David Healy cautions that histories of chlorpromazine have been too 
narrowly focused on whether or not the drug was responsible for the 
closure of asylums. He argues that what was equally significant was that 
by reducing the numbers of patients with serious symptomatic psycho-
sis, less severe symptoms of neurosis and depression duly emerged at 
the forefront of psychiatric practice.5 Indeed, chlorpromazine was fol-
lowed closely by the first compound of a group of drugs that were to 
become known as the ‘minor’ tranquillisers for the treatment of anxiety 
disorders. Meprobamate, sold in the United States under the trademark 
as Miltown, and in Britain as Equanil, became the  best- known drug of 
its kind until the discovery of chlordiazepoxide (Librium), the first of 
the benzodiazepine tranquillisers.6 Diazepam, the second of the benzo-
diazepines, was introduced in 1963 and its trade name Valium came to 
be used almost generically to mean ‘tranquilliser’.7 Commentators soon 
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suggested that the calming effects of the benzodiazepines were ‘unique’ 
and even ‘remarkable’, and studies showed that they were much safer in 
overdose than existing hypnotic sedative preparations.8 However, con-
cerns were soon raised about the potential for dependence and indeed, 
by the 1970s, it emerged that large numbers of people were addicted to 
benzodiazepines.9
Increasingly, optimism surrounded the pharmacological treatment of 
both endogenous and reactive depressions. A group of drugs known as 
the tricyclics proved promising in the treatment of classic endogenous 
depression, whereas ‘atypical’ or reactive depressions appeared to react 
favourably to monoamine oxidase inhibitors (MAOIs), particularly 
where symptoms of depression were aggravated by anxiety. In many 
cases, patients were prescribed both an antidepressant and a benzodiaz-
epine. As Callahan and Berrios have noted, psychotherapeutic, or ‘talk-
ing’ methods of treatment for minor mental illness proved impractical 
in a primary care setting.10 As the oral testimonies in this book from 
physicians suggest, doctors were faced with short consultation times, 
large lists of patients and minimal ancillary support. The pharmacologi-
cal treatment of depression and anxiety therefore became entrenched 
during this period.
It is important to remember that, although the new drugs expanded 
the pharmacological options available to physicians, the use of pre-
scribed psychoactive substances has a much longer history. Many of 
the older drugs, such as amphetamines and barbiturate sedatives, con-
tinued to be prescribed alongside the newer ones. Some of them were 
also used in combination preparations alongside other compounds for 
the treatment of a wide range of psychological and physical complaints 
ranging from appetite suppressants to treatments for gastric discomfort. 
By the time of Parish’s seminal study of  psycho- pharmaceutical pre-
scribing published in 1971, the benzodiazepines, tricyclics and MAOIs 
were the drugs of choice; however, significant numbers of prescriptions 
for phenobarbitone and sodium amytal (barbiturates) were still being 
administered (see Table 4.1).
Between 1965 and 1970, the prescribing of all tranquillising drugs 
increased from 10.8 million prescriptions to 17.2 million. This rise was 
largely due to a 110 per cent increase in prescriptions for the minor 
tranquillisers. During this  five- year period, for example, the annual pre-
scribing of Librium increased by 1.15 million and Valium by 4.1 million. 
Parish noted that such a significant rise could not be accounted for by 
the concomitant decrease in the use of the  older- style sedatives, which 
had declined only moderately.11 The period also saw a considerable rise 
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Table 4.1 Number of prescriptions, psychotropic drugs (England and Wales  – 
in millions)
1965 1966 1967 1968 1969 1970
Barbiturate hypnotics



































Total 39.7 41.9 45.3 46.3 46.4 47.2
Source: ‘The prescribing of psychotropic drugs in general practice’, Journal of the Royal College 
of General Practitioners, Supplement 4 (1971), 1. Reproduced with kind permission from the 
Royal College of General Practitioners.
in the use of  non- barbiturate hypnotics, particularly the drugs Mandrax 
and Mogodon that were prescribed for sedation and insomnia.12 
Antidepressant prescribing increased consistently during the  five- year 
period; however, a pronounced rise in the use of antidepressants did not 
occur until later in the 1970s and into the 1980s.
From the records of  forty- eight GPs examined in Parish’s study, 
17.1 per cent of prescriptions were for women and 8 per cent were for 
men.13 For women, the trend showed a progressive increase in prescrip-
tions up to the age of  forty- five. After this age, numbers decreased until 
the age of seventy when they rose sharply again. Trends in prescribing 
to men illustrated a more steady, but moderate increase throughout 
their lifetime.14 The male to female ratio remained relatively consistent 
between doctors and between practices (see Table 4.2), but there were 
 inter- practice variations in the overall percentage of patients prescribed 
psychotropic drugs and large differences in the use of different psycho-
therapeutic groups.15 Some physicians preferred to use tranquillising 
drugs; others opted more commonly for antidepressants. One doctor, 
for example, used none of the popular psychotropic drugs, and gave 
most of his patients ‘Beplete Syrup’ (a vitamin and barbiturate combi-
nation). These differences led Parish to caution that reports of overall 
prescribing were therefore of rather limited value.16 Stimulants and 
appetite suppressants were in all cases much more frequently prescribed 
to women, usually for weight loss, although overall prescribing of 
amphetamines decreased through the period due to increasing concerns 
about tolerance and addiction.17 Parish’s study reflected the findings of 
research undertaken during the previous decade that revealed large vari-
ations in prescribing patterns between doctors. A study of prescribing 
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patterns in three northern towns, for instance, also illustrated that ‘not 
only the choice of individual remedies but also the proportion of rem-
edies in different therapeutic groups show much difference between 
individuals, as do the rates per thousand patients on the doctor’s lists’.18 
Ultimately, such studies raised many questions about the true extent 
of psychiatric morbidity but provided few answers. As Parish noted at 
the end of his discussion, the results of his study had highlighted some 
interesting problems that required further research. First and foremost 
of these, he asked, was the question: ‘Why are twice as many women as 
men prescribed psychotropic drugs?’19
Behind the data: a complex picture
There are a number of reasons why it was impossible to determine the 
true extent of psychiatric morbidity in the community, or draw conclu-
sions about the gendered distribution of illness, based on prescribing 
data. First of all, from the 1960s, doctors were  ill- prepared for the sud-
den increase in therapeutic preparations. Doctors entering practice in 
the late 1950s and early 1960s had few pharmacological choices avail-
able to them. General practitioners recalled that, until the  mid- 1960s, 
they primarily used a range of ‘tonics’ that were dispensed in a variety of 
colours and available in different strengths. Giles Walden, upon arriving 
at his first post in 1963, found that the three existing doctors dispensed 
two types of tonics – one that was dark brown, the other light brown: 
Table 4.2 Psychotropic drug therapy, sex ratios (17.1% women to 8% of males 
per population at risk)
Therapeutic  sub- group Number of treatments Ratio
Female Male Total Female to male
Barbiturate hypnotics
 Non- barbiturate hypnotics
Tranquillisers























Total treatments 1,635 733 2,368 2.21 to 1
Total sample of patients 1,140 528 1,668 2.14 to 1
Source: ‘The prescribing of psychotropic drugs in general practice’, Journal of the Royal College 
of General Practitioners, Supplement 4 (1971), 20. Reproduced with kind permission from the 
Royal College of General Practitioners.
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‘What was in it, I just don’t know, but I mean that was their armament 
really, barbiturates and these tonics with a bit of strychnine in, you 
know.’20 Among the medical profession, the term ‘tonic’ in this period 
indicated a preparation with  muscle- building or ‘toning’ properties, 
often containing strychnine; however, the word was used more loosely 
by the public who perceived tonics to improve health more generally or 
to remedy some kind of ‘deficiency’.21 Christian Edwards remembered 
prescribing tablets he described as ‘pink, blue and white aspirins’, and 
added that ‘the pink worked much better than the blue and not as good as 
the white, or something’.22 Richard Stanton, who, after qualifying, 
fulfilled a number of locum posts, said that he would never forget what 
he encountered in one doctor’s consulting room:
On this guy’s  desk- blotter, he had written about twenty drugs around 
the edge, and that was his whole pharmacy. That was all he ever 
gave out. I asked one of the partners, ‘What’s this all about?’ He said, 
‘That’s all he ever uses, those twenty drugs.’23
A number of doctors pointed out that tonic preparations often acted as 
a kind of placebo and that in some respects the demand for them was 
 patient- led. Stanton recalled:
They might actually come in and one of the words that people used 
was ‘Doctor, I think I need a tonic . . .’ which of course was put into 
their minds, because doctors prescribed a tonic. ‘Let’s go down [to] the 
doctor and get a tonic, then I’ll feel better’. So we responded to that. 
I mean that, that was the traditional approach.24
Giles Walden described a very similar situation:
All they wanted was their bottle of the usual red stuff, or green stuff 
[laughing] – or even the blue medicine. ‘That’s all I want Doc’ – you 
know. And this used to be prescribed and off they went. And to begin 
with there was little emphasis on trying to find out what it was for or 
why they needed it. I sort of found myself having to go along with 
this to begin with . . . but I soon began to question what it was that 
we were dishing out, and for me, things began to change.25
As new drugs for anxiety and depression were developed, the range 
of treatments became increasingly sophisticated and general practi-
tioners (GPs) were largely required to do their own research into the 
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pharmacological properties of the various groups of drugs. A  quick 
glance at the pharmaceutical reference book, the British National 
Formulary (BNF), used widely by GPs, illustrates the marked increase 
in preparations between the early 1950s and the 1970s. The only 
drugs listed for psychological disorders and insomnia in the 1952 edi-
tion were categorised under the heading, ‘Drugs acting on the central 
nervous system’. These included barbiturates, potassium bromide, 
amphetamines, analgesics and anaesthetics.26 Other drugs noted to 
be of use in stimulating appetite, and as acting in part ‘through psy-
chological mechanisms’, were listed under the heading ‘Bitters and 
tonics’. Preparations included strychnine and iron, gentian with alkali 
or acid, and Nux Vomica with alkali. These mixtures have a long his-
tory of medicinal use in tonic preparations – strychnine, for example, 
in  non- toxic doses was regarded as a stimulant and often used for res-
piratory and cardiac conditions.27 By 1957, the major  anti- psychotics, 
chlorpromazine and reserpine, were added to the list of drugs acting 
on the central nervous system, and in 1960, a new category of ‘seda-
tives and tranquillisers’ appeared. By 1960, there were new warnings 
about drug dependence and a dedicated section of the reference 
book entitled, ‘ Habit- forming drugs’ (largely composed of hypnotics, 
sedatives and analgesics).28 In 1963, the catalogue of entries expanded 
extensively to include the new benzodiazepine, Librium; the tricyclic 
antidepressant, imipramine; a range of MAOI antidepressants; and the 
minor tranquilliser, meprobamate.29 Although a new distinct category 
of ‘Antidepressants’ appears in 1963, the broad format of the publica-
tion remained the same. The new drugs were simply listed in the front 
section as ‘additions’, with no detailed discussion about individual 
preparations. In less than ten years, thus, the pharmacological options 
available to physicians expanded considerably – yet data on their effi-
cacy was to be hotly debated, and at times disputed, for many years 
to come. The BNF did not change its format significantly until 1974, 
when the publication split into two separate sections: the first, enti-
tled ‘Notes on drugs’, provided detailed information and discussion 
about drugs under specific pharmacological classifications; the second 
provided a summary of preparations with specifications regarding dos-
age and contraindications to their use. It is notable that, by the 1974 
edition, all reference to the psychological component of tonic prepara-
tions disappears altogether as the category of ‘Bitters and tonics’ disap-
pears, to be replaced with the heading ‘Nutrition and blood’ – perhaps 
a discernible marker of the increasing shift towards a reductionist 
medical model of mental illness.
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Given the considerable expansion in available treatments for 
 psychological symptoms, general practitioners were provided with a 
limited range of methods for keeping abreast of new drugs. Many of 
them turned to pharmaceutical prescribing reference publications such 
as the BNF and the Monthly Index of Medical Specialities, referred to as 
MIMS. Some asked for advice from local hospital consultants in an 
attempt to gain specialist knowledge, and others conferred with their 
colleagues in primary care. GPs recalled that, during these years, the 
BMJ and the Lancet published very little on  psycho- pharmaceuticals 
that might assist doctors with the  day- to- day realities of prescribing.30 
At the centre of debates on sources of therapeutic information was 
the concern that undergraduate medical training focused primarily 
on the basic medical sciences and less on pharmacology. During  pre- 
 registration training and thereafter, the acquisition of knowledge in 
this area was primarily the responsibility of the individual doctor.31 
One research article noted specifically that the rapid advances in phar-
macology had made a very large number of compounds available for 
medical treatment, but that there was ‘no necessity for a doctor to 
acquaint himself with any information about these new compounds. 
If he does attempt to do so, where and how he does this is wholly his 
own decision’.32 The study, which included a sample of prescribing over 
one week by a group of GPs in Liverpool, indicated that when treating 
serious physical disease, general practitioners were more inclined to rely 
on their former clinical training. This was predominantly the case for 
heart disease, for example, with advice from consultant cardiologists 
where necessary. In contrast, when presented with psychological dis-
orders, peptic ulcer and dyspepsia, doctors were more likely to consult 
handbooks such as the BNF  – and take advice from pharmaceutical 
representatives.33 The study suggested that British doctors, particularly 
older doctors, depended on information from drug companies where 
advances in therapeutics had occurred since their medical training had 
ceased.34 Dunnell and Cartwright’s study, Medicine Takers, Prescribers and 
Hoarders, published in 1972, reflected these findings, suggesting that 
one of the most important sources of information about new drugs was 
the literature produced by drug firms. In this research, 45 per cent of 
doctors questioned had seen five or more  drug- firm representatives in 
the previous four weeks and only 6 per cent had not seen any.35
The growing range of drugs available, the lack of training, the pro-
liferation of advertising and the concurrent increase in prescribing, 
caused considerable concern and attracted criticism in the medical 
press. This was summarised opportunely by Derrick Dunlop, Chair 
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of Therapeutics and Clinical Pharmacology at Edinburgh University, 
who noted: ‘Nowadays, when we are  Jove- like in the therapeutic 
thunderbolts we hurl – drugs potent for evil as well as for good – it is 
of paramount importance for us to be thoroughly conversant with 
the pharmacological tools of our trade.’36 Parish, in his comprehensive 
study of pharmaceutical prescribing, raised specific concerns about the 
sources of information available to general practitioners, warning that:
It is difficult to see how the general practitioner can have access 
to concise and unbiased information and how he has time to sift 
out objective data, which he needs if he has to make rational 
 therapeutic decisions. Huge sums of money are spent annually to 
advertise drugs to prescribers, and the prescribing patterns and rates 
of general practitioners indicate how effective these promotional 
efforts are.37
In May 1965, the Ministry of Health set up a Committee of Enquiry 
into the Relationship between the Pharmaceutical Industry and the 
NHS, under the Chairmanship of Lord Sainsbury. In its conclusion, the 
committee confirmed many of the concerns articulated in the medical 
press, which stated that some of the sales material produced by pharma-
ceutical manufacturers failed to measure up to the required standards in 
informing doctors adequately about new (and existing) preparations.38 
Parish was critical that the claims made by manufacturers placed sig-
nificant pressure on general practitioners because, with ‘such a torrent 
of information pouring on to him, [he] can cope only by having details 
of a particular drug and its effects brought clearly to his notice’.39 
Ultimately, Parish maintained that responsible and appropriate pre-
scribing could only be promoted by a system of continuous therapeutic 
education at undergraduate and postgraduate level.40
The influence of pharmaceutical advertising on doctors ultimately 
contributed to the eclipse of male psychological illness. Manufacturers 
reinforced and exploited stereotypical gender roles in their marketing 
material, prompting doctors to prescribe drugs from within a traditional 
framework that assumed women were more commonly affected by 
mental disorders. Additionally, drug firms produced combination prep-
arations that were less obviously ‘psychotropic’ in their action because 
their primary agent was designed to treat an organic condition, such 
as peptic ulcer or appetite loss. Many of these drugs were not classed 
as ‘psychotropic’, yet they often contained psychoactive compounds – 
which might either sedate or stimulate.
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Studies on  psycho- pharmaceutical prescribing during this period 
were undertaken within the framework of the WHO’s classification of 
psychotropic drugs. The operational definitions were divided into five 
groups: neuroleptics (major tranquillisers); anxiolytic sedatives (minor 
tranquillisers); antidepressants (tricyclics and MAOIs); psychostimu-
lants (amphetamines); and psychodysleptics (hallucinogens).41 A num-
ber of other drugs were also being investigated at this time, among them 
being lithium for use in what was then known as  manic- depressive 
disorder, and methadone for use in the treatment of narcotic addiction. 
However, preparations for other physical conditions that combined two 
compounds, one of which was a psychotropic drug, were invariably 
excluded from the WHO classification framework and subsequently 
from studies on  psycho- pharmaceutical prescribing trends. Parish, for 
example, stated clearly at the beginning of his study that, ‘admixtures’ 
in which the psychotropic drug was not the main constituent were 
excluded.42 In broader studies of prescribing trends, combination drugs 
most usually fell under the classification ‘drugs acting on the digestive 
system’ or under the  ill- defined category, ‘others’.43 The most com-
monly prescribed admixtures were those used to treat gastric discomfort 
from peptic ulcer or indigestion and were, as such, most commonly 
prescribed to men. They usually contained a compound to reduce 
stomach acid and a tranquillising agent to reduce anxiety, which, as 
this book has suggested was strongly associated with peptic ulcer during 
the period. The manufacturers Roche, for example, widely marketed a 
drug called Libraxin during the late 1960s and 1970s, which contained 
the benzodiazepine Librium and clidinium bromide, a compound that 
reduces stomach cramping and acid production. The company claimed 
that ‘By reducing anxiety and aggression, and by its anticholinergic 
activity, Libraxin blocks reactions which increase gastric secretions and 
inflame gastric mucosa.’ In fact, claimed Roche: ‘Libraxin usefully calms 
both the stomach and the patient’.44 The drug, Nactisol, produced by 
Beecham Laboratories, acted in a similar fashion, containing a com-
pound for ulcer management combined with a barbiturate sedative for 
cases ‘where anxiety complicates ulcer management’.45 Stelabid, pro-
moted widely during the 1960s by Smith Kline and French, claimed to 
‘settle the matter’ in a ‘wide range of  gastro- intestinal disorders’. This 
drug contained an  anti- spasmodic with an  anti- psychotic compound, 
and the marketing material claimed that it ‘exerts a beneficent calm-
ing action which effectively allays the background stress and worry 
that so often provoke or aggravate such conditions’.46 Another widely 
promoted admixture was the drug, Durophet M, which was a sedative/
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stimulant combination, used to aid the ‘psychological difficulties of 
dietary restriction’ in obesity.47
It is difficult to say precisely how widely GPs prescribed these drugs. 
The position held by editors of the BNF on their efficacy was defini-
tively negative, and it is noted in the  1974– 6 edition that, compared 
to other publications from the industry, there were fewer compound 
preparations discussed in the handbook. Describing them as ‘a relic of 
the whimsical mixtures of our predecessors’, the editors were of ‘the 
austere view that such preparations pander to bad practice’, and it was 
recommended instead that, ‘each drug should be given in its optimum 
dosage, which is not possible in a fixed combination’.48 The same mes-
sage was reiterated in the subsequent issue ( 1976– 8) under the section 
on drugs that act on the alimentary system, where the advice was 
unequivocally that combination drugs should be avoided.49 This posi-
tion was supported by a number of doctors during interview where the 
criticism laid against combination preparations was that if the patient 
improved following the administering of the drug, it was not possible to 
tell which compound had produced improvement. Christian Edwards, 
for example, stated that he was ‘brought up on  single- drug prescribing’ 
and avoided combinations  – ‘tempting though it was’. His concern 
was about  side- effects and he put forward an analogy to describe the 
potential problems: ‘It’s like riding two bicycles at the same time, you 
don’t know which one to brake on.’50 Another doctor recalled that the 
drugs were ‘very heavily advertised’ but that he had not prescribed 
them because they ‘clashed’ with his attitude to medicine, noting that, 
‘If the patient got better, you had no clue which bit of it was helping.’51 
In contrast, other doctors used them routinely and spoke favourably 
about the broad concept. Glen Haden maintained that the combination 
drugs for stomach disorders were ‘very effective’, and he recalled that he 
used to prescribe Libraxin in ‘vast quantities’.52 Rupert Espley confirmed 
that during his early years in practice, the convention of ‘putting a little 
bit of sedative into things’ was relatively widespread, and, laughing, he 
recalled one dispensing surgery where colleagues would ‘put a little bit 
of phenobarbital in the bottle of medicine, according to the amount 
they felt was needed’. When asked to clarify to which medicines this 
might apply, Dr Espley replied, ‘Oh, in a bottle of medicine for magne-
sium trisillicate for dyspepsia or something like that.’53 Undoubtedly, 
some in the medical community frowned upon the use of combina-
tion drugs; nevertheless, the proliferation of adverts for such prepara-
tions does suggest that a considerable market existed for those who 
favoured the approach. As Roger Lea (a West Country GP) observed, the 
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pharmaceutical companies collated large amounts of data on prescrib-
ing trends. He eventually refused to meet with drug representatives, 
because ‘they would come in with a headful of data about my prescrib-
ing habits, and what I did – you know – how to make me feel good … 
I reckoned they were too good at it.’54
Since research suggested older GPs were more likely to rely on infor-
mation from drug companies, it would be reasonable to suggest that 
these drugs were probably prescribed in significant numbers, and most 
commonly to men, where anxiety featured as an aspect of some physi-
cal disorder. Yet official data on the prescribing of psychotropic drugs 
did not reflect the use of these preparations and continued to provide 
compelling evidence that women consumed significantly greater 
amounts of drugs in all psychotropic categories. In the late 1970s, 
the Canadian researcher Ruth Cooperstock, who published widely on 
gender and psychotropic drug use, suggested that the use of these com-
pounds was being underestimated in data; however, little attention was 
paid to the topic in Britain. Cooperstock claimed that, in Canada, the 
use of mixed drugs had expanded throughout the 1970s ‘to include all 
varieties of somatic disorders and their emotional sequelae’.55 Using the 
drug, Stelabid, as an example, she observed that:
In 1973, there were as many prescriptions for Stelabid, a mixed psy-
chotropic, as for Stelazine, the pure tranquilizer. Stelabid, however, 
is termed an antispasmodic drug and is never identified as a psycho-
tropic, consequently deflating the actual proportion consumed.56
A year later, in a sociological study of  gender- role conflict and benzo-
diazepine use, Cooperstock maintained that male use of tranquillising 
agents tended to be related to conflict regarding work performance, ‘or 
more typically, the need to contain somatic symptoms in order to per-
form an occupational role’. She argued that men in her study were less 
emotionally expressive than women, ‘a consequence of which appeared 
to be greater emphasis on reports of somatic problems’.57
 Self- medication
Parish’s study of pharmaceutical prescribing patterns revealed that not 
only had the taking of prescribed medicines increased, but the use of 
 non- prescribed or  so- called ‘ over- the- counter’ drugs had also increased 
dramatically. In 1968, £80 million of  non- prescribed medicines were 
purchased.58 He pointed out that since only  one- third of illness episodes 
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were presented to the general practitioner, it would appear that the 
practice of  self- medication was not influenced by doctors’ attitudes and 
concepts. Dunnell and Cartwright’s extensive study of  medicine- taking 
revealed that, of those interviewed,  three- quarters of the women and 
 three- fifths of the men had taken some  self- prescribed medicine in 
the past two weeks.59 The authors emphasised that higher numbers of 
women taking  over- the- counter medicines might be accounted for by 
the fact that women generally took responsibility for the family shop-
ping and were therefore the ones exposed to persuasive advertising 
for remedies in shops. They further cautioned that reported behaviour 
was not necessarily actual behaviour and evidence from the previous 
chapters in this book suggests that men might well have been reluctant 
to admit taking remedies for ailments.60 The figures for  non- prescribed 
medication certainly led Dunnell and Cartwright to conclude that a 
large ‘iceberg’ of illness existed in the community at any one time that 
was not known to the medical profession.61
A survey of advertising for home remedies throughout the 1950s and 
1960s certainly suggests that there was a sizeable market for medicines 
and tonics that claimed to relieve stress, and symptoms of indiges-
tion and other digestive disorders. Prior to the 1950s, pharmaceutical 
companies exploited the wartime market, both in Britain and abroad, 
expounding the positive effects of tonics to markets in West Africa 
and Burma, for treatment  post- malaria and other tropical illnesses.62 
Adverts were framed within stereotypical gender roles. Sanatogen 
tonic, for example, was targeted at women for promoting and main-
taining beauty. One advert claimed: ‘The bloom of youth often leaves 
a woman early through fevers and the weakening influence of the 
climate.’ Another reminded audiences that: ‘A healthy youthful wife 
is a joy to her husband.’ The makers of the tonic also claimed that it 
would ‘banish weakness’ and ‘restore health’ in men.63 At home, the 
makers of Rennies indigestion tablets used images of military person-
nel in their adverts, which appeared regularly in national newspapers. 
They claimed that ‘ war- time indigestion’ was caused by ‘worry, sus-
pense and hurried meals’. ‘A couple of Rennies’ would help ‘stomach 
pains to stop naturally’.64 Other adverts drew upon images of suited 
businessmen and the notion of acid stomach caused by stress at work. 
One alarming advert released in national newspapers featured a pic-
ture of a large burned carpet, accompanied by the text: ‘The acid in 
your stomach would burn a hole in a carpet.’ The notion that men 
should ‘stand up’ to their indigestion was implicit in all adverts and 
demonstrated in a promotional piece for Rennies, which depicted a 
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 hard- working warden, looking for ‘easy instant relief’, whose ‘job was 
tough, but his indigestion was tougher’. Another image prompted 
men not to become ‘indigestion martyrs’.65 War workers, business 
executives and working class men all appeared in adverts for the same 
products, but could be distinguished by their dress: military uniform, 
suits and hard hats or flat cloth caps respectively. Women appeared 
occasionally in images during the war years, referring to traumatic 
circumstances such as air raids and appearing in images of factory 
work, where time pressures and unappetising meals were seen to cause 
a problem with digestion. However, during the war, the images were 
predominantly of men.
 Post- war, manufacturers of tonics and indigestion remedies employed 
a range of strategies to engage with the male market. Arguably, the 
theme of defeating weakness and regaining strength was the most com-
mon way in which advertisers resonated with the beliefs and values 
associated with contemporary masculinity. Socialisation into the male 
role began early, evident in marketing images that depicted small chil-
dren, such as the advert for Horlicks shown in Figure 4.1.
In this instance, the manufacturers claim explicitly that ‘Little boys 
are made of GOOD STRONG BONES, good tough muscle, and of loving 
care’. A  mother’s loving care therefore required that she provide her 
sons with the correct nutrition so that they may ‘build their bodies into 
that strength on which health and happiness depend. Setting already 
the wise habit of a lifetime’.
As numerous authors have noted, advertisements are one of the 
most important cultural factors reflecting, moulding (and remoulding) 
everyday life.66 Although, from this study it is not possible to measure 
their influence, the motivational psychology behind such adverts is 
clear from archival collections of draft drawings and copy text filed in 
advertising agencies’ guard books. Figures 4.2 and 4.3, for example, are 
images in the early stages of design for the product Iron Jelloids, which 
was a tonic preparation sold widely during the 1950s.
As Figure 4.2 suggests, this product claimed essentially to do two dif-
ferent things. Where a woman is pictured, the adverts suggests that Iron 
Jelloids might make her look ‘lovelier every day’, in contrast to the image 
of a man seen participating in a tug of war, where it is intimated that 
the product might make men ‘feel stronger every day in every way’. For 
the suited gentleman who featured in the guard book image in Figure 
4.3, Iron Jelloids appear to transform the man’s sullen, grey complexion, 
from ‘Weakness’ to ‘A1’ condition, the metamorphosis duly represented 
by a much brighter, healthier and stronger looking appearance.
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Figure 4.1 Advertisement for Horlicks, Radio Times, 6 December 1957
Source: Reproduced by kind permission of GlaxoSmithKline and the History of Advertising 
Trust Archive.
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Figure 4.2 Iron Jelloids advert design, circa 1950s
Source: Reproduced by kind permission from Reckitt Benckiser and the History of Advertising 
Trust.
Advertisers increasingly began to draw on  well- known figures and tel-
evision personalities to endorse their products. The makers of Macleans 
indigestion tablets employed the television host, Gilbert Harding, to 
advertise their product in 1959. During the 1950s, Harding hosted the 
BBC Radio show, I Beg to Differ, and became infamous for his abrupt, 
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Figure 4.3 Iron Jelloids advert design, circa 1950s
Source: Reproduced by kind permission of Reckitt Benckiser and the History of Advertising 
Trust.
outspoken and sometimes rude behaviour. He went on to feature as a 
regular panellist on the BBC  light- entertainment programme, What’s 
my Line? Harding’s brusque and direct approach was applied skilfully 
in marketing Macleans Tablets, where he appeared to be expressing 
his frustration with ‘people who just don’t bother to think for them-
selves’ and who ‘never stop complaining’. For indigestion sufferers, 
according to Harding, there was simply no excuse for complaining, or 
for ‘ suffering’ from pain – Macleans Tablets were the obvious answer. 
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Figure 4.4 Advert for Macleans Tablets, 1959
Source: Reproduced by kind permission from GlaxoSmithKline and the History of Advertising 
Trust.
Harding claimed to always carry some in his pocket and suggested that 
‘anyone with any sense’ should do the same (See Figure 4.4).67
Although the majority of advertisements directed at men harmo-
nised with the theme of restoring physical strength, vitality and vigour, 
manufacturers increasingly indicated that men were also vulnerable 
to psychological stress. Drawing on contemporary scientific studies 
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of stress, and on broader cultural anxieties about the negative health 
consequences of modern living, the makers of the tonic, Phosferine, 
produced numerous adverts depicting men with what they described 
as ‘nervous exhaustion’. The testimonial featured in the advert for 
Phosferine in Figure 4.5 indeed states explicitly that nerve trouble, for 
this particular gentleman, caused him to fear train and bus journeys. 
The cause of ‘stress’ nonetheless, in this case, was located in the ‘gastric 
nerves’, causing loss of appetite and lack of sleep. This was in contrast 
to the claims increasingly put forward by pharmaceutical companies for 
prescribed psychotropic drugs, which claimed to act directly on chemi-
cals in the brain and not the nervous system.68
Advertisements for  over- the- counter preparations also reflected the 
social changes that took place from the end of the Second World War. 
Although most women, certainly through the 1950s and into the 1960s, 
still fulfilled their primary role at home as wives and mothers, men 
had begun to increase their engagement with family and domestic life. 
A  series of fictional,  drama- style advertisements for Horlicks mirrored 
the developments in gender roles, featuring men in roles as husbands 
and fathers. The male protagonist in these adverts would invariably 
be ‘grumpy’ and exhausted, often upsetting his wife and children. In 
one advert, published widely in the national press during the  mid- 
 1950s, a father is pictured rejecting a  hand- made wooden gift from his 
son, irritated by the noise the boy had created when constructing it. 
Another scene depicted a policeman whose tiredness had caused him 
to neglect his son, resulting in delinquent behaviour. Both examples 
reflect the increasing social and cultural importance of the male role 
in the home and at the centre of the family. In all cases nonetheless, 
male protagonists needed prompting by their wives to seek help from 
the doctor, who invariably confirmed that drinking Horlicks at night 
might aid sleep and relaxation. Miraculous transformations to mood 
and manner ensued. The makers of Horlicks also utilised the charms 
of the  well- known actor, novelist and columnist, Godfrey Winn, in a 
‘problem page’ style advert during the late 1950s. Winn was known for 
his popularity with a female audience and regularly contributed to the 
BBC Radio show, Housewives’ Choice. An advert for Horlicks in 1957 fea-
tured a letter from a gentleman seeking Winn’s advice about insomnia. 
Not only was the complainant ‘miserable’ himself, but he confessed 
that he ‘made the whole family the same  – especially [his] wife who 
became a bundle of nerves and had to seek medical aid’. It is likely 
such letters were entirely fictitious; however, it is interesting that this 
scenario echoed the accounts put forward by many family doctors who 
maintained that women often sought medical help for stress and nerves 
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Figure 4.5 Advert for Phosferine, 1955
Source: Reproduced by kind permission from GlaxoSmithKline and the History of Advertising 
Trust.
caused by living with a family member with psychological problems. 
At the end of Winn’s advice page, he cautioned against ‘taking sleeping 
pills’,  reassuring readers that his ‘Horlicks postbag’ was full of similar 
cases – yet taking Horlicks would undoubtedly ensure that life would 
become a ‘better and happier thing’.69
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The manufacturers of indigestion remedies either drew an associa-
tion with poor diet and irregular meals and dyspepsia, or, as was the 
case with Maclean’s Tablets and Rennies, increasingly they claimed 
a link between worry and indigestion. In Rennies’ adverts, the  tag- 
 line: ‘Dyspepsia  – sometimes started by worry, invariably stopped by 
Rennies’ appeared often.70 One promotional advert released by the 
same company and published in the Daily Mail and the Daily Express 
claimed to carry a medical seal of approval and featured a cartoon 
image of a doctor with a stethoscope around his neck, who had osten-
sibly ‘cured his own stomach trouble after hospital treatment failed’. 
Worried and overworked, dealing with a large list of patients and struck 
down with gastric symptoms, the ‘doctor’ (whose name was omitted) 
claimed that gastric pain, heartburn and acidity ‘disappeared in a mat-
ter of seconds after taking a couple of [Rennies]’. Promoting the ‘unu-
sual medicinal qualities’ of Rennies tablets, the manufacturers claimed 
that in addition to this doctor, 1,193 other doctors had also written 
to say they were prescribing the tablets for their patients as the most 
effective treatment.71
Although it is not possible to quantify with any accuracy the extent 
to which men were purchasing home remedies for minor ailments, the 
widespread and consistent advertising of such products suggests that a 
strong and viable market existed. Accounts from doctors certainly sug-
gest that men were more comfortable treating minor ailments them-
selves than attending the doctor’s surgery, and as we have seen, women 
played a central role in persuading men to seek medical help and in 
stocking the medicine cabinet as part of the weekly family shop.  Over- 
 the- counter remedies certainly afforded men the opportunity to treat 
conditions themselves and manufacturers often exploited the idea that 
they were reluctant to seek medical help. An advert for a product called 
Hemotabs, indicated for use in the treatment of haemorrhoids, provides 
a typical example. Depicting an image of a male, the makers noted that 
‘after years of suffering in silence’, the product would bring relief.72
Reﬂ ections
Parish observed in his study during the early 1970s that research on the 
topic of  psycho- pharmaceutical prescribing had been unable to produce 
‘any firm conclusions’. Results, he pointed out:
. . . depend upon the size of the sample, the diagnostic classifications, the 
indices of morbidity, the system of sampling, the methods of recording 
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data, and above all, upon the attitudes towards mental illness of the 
researchers and the general practitioners being investigated.73
Until the development of computerised records, not all doctors kept 
accurate records of prescribing data.74 Studies were therefore reliant 
upon those who kept records and were willing to submit them for 
research. Such doctors were a  self- selected group and we know very little 
about the prescribing habits of those doctors who did not keep accurate 
records. Reports of mental illness were also only based upon patients 
who attended their GPs. As Parish pointed out, these too were ‘a  self- 
 selected group of persons whose attitudes and expectations may differ 
from those who do not attend and yet suffer from symptoms’.75 In his 
report, Parish neatly summarised many of the methodological obstacles 
faced in previous research:
In the past, many of these survey findings have not been corrected 
for age and sex differences, and the period of the surveys has varied 
from anywhere between one week and five years. It is also obvious 
that the parameters on which reports of mental disorders in general 
practice are based need challenging, particularly the present defi-
nitions of what is abnormal and what is normal mental health … 
When does a ‘person’ become ‘a patient’? Where is the  cut- off point 
in deciding whether a person is ‘neurotic’? … Further, there is little 
doubt that the estimated extent of ‘mental illness’ is higher when 
assessed in the community than when assessed from general practi-
tioners’ consulting rooms, and this difference can only be explained 
by differences in attitude towards mental illness and towards general 
practitioners.76
Research published during the early 1980s began to consider some of 
these factors in more detail and to reflect on the influence of gender 
stereotyping upon prescribing. In a longitudinal study of psychotropic 
drug prescriptions undertaken at the General Practice Research Unit, 
Institute of Psychiatry in London, doctors were asked to record the 
complaints presented to them by patients at the initial consultation. 
The study found that a much greater proportion of women ‘described’ 
classical symptoms of depression, whereas a larger proportion of men 
complained not of depression, but of other physical symptoms – and 
frequently of sleep disturbance.77 The study also revealed that more 
women than men received a tranquilliser for depression (in addition to, 
or in place of an antidepressant). The researchers were unable to explain 
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why this might be and subsequently urged that this be explored more 
fully in future research.78 Commentators began to suggest that psycho-
tropic drugs, and tranquillisers in particular, were being prescribed to 
remedy symptoms caused by social and not medical problems. As Kevin 
Koumjian noted in the early 1980s, social problems related to family, 
work and other spheres of social life were increasingly being defined 
as medical problems – for which a medical solution could be sought.79 
Sociological, psychological and political interest focused on this topic, 
in part prompted by claims put forward by the feminist movement that 
suggested the limited opportunities afforded to women were stifling 
and oppressive, causing them to experience depression and anxiety.80 
Historians of medicine now debate the extent to which this was in fact 
the case. However, a point made less frequently was that women were 
certainly more at ease articulating social problems to their doctor and 
would seek help and advice in situations where men were more reticent. 
Much of the research undertaken on both sides of the Atlantic from 
the late 1970s suggests that women were more comfortable confiding 
in doctors about strains in family groups, marital difficulties and the 
pressures of raising children.81 The increasing medicalisation of daily 
problems meant that it was therefore almost inevitable that more 
women would be prescribed psychotropic drugs. Research undertaken 
by Joanna Murray, again from the General Practice Research Institute, 
revealed that women on  long- term drugs felt that they required medica-
tion for a wide range of daily functions, including: travelling, shopping, 
mixing with people and running their homes.82 The more intensely 
commentators focused on women’s consumption of psychotropic 
drugs, the less likely it was that the spotlight might shine on presenta-
tions of male distress and the reasons why men were prescribed drugs 
less frequently.
As the other chapters in this book have shown, there is some evidence 
that doctors’ views about the gendered distribution of mental illness 
influenced consultations with their patients and subsequent prescribing 
habits.83 The view that women were hormonally predisposed to psychi-
atric symptoms, for example, remained prevalent throughout the 1960s 
and 1970s – a point that featured in many of my interviews with doc-
tors. Parish too, noted in his study, that disorders of menstruation and 
the menopause were common physical disorders for which psychotropic 
drugs were prescribed – in particular the minor tranquillisers, Librium 
and Valium. According to his research, one in twenty of all patients pre-
scribed such therapy were women with these ‘disorders’ which included 
not only puerperal depression and menopausal depression, but also 
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dysmenorrhoea in younger women and other menopausal symptoms 
which, it was noted, ‘appeared to cause much suffering’.84
Published sociological research certainly began to suggest that tran-
quillisers were used increasingly to help individuals tolerate difficult 
personal circumstances. Many of these individuals were women who 
were living with partners who might have been displaying psychologi-
cal symptoms but remained undiagnosed. Researchers pointed to cases, 
for example, where women were prescribed drugs to help them adapt 
to conflict in marriage and to intolerable behaviour by alcoholic hus-
bands.85 Although many women saw no alternative to pharmaceutical 
treatment, others expressed anger about their physicians’ approach 
and found alternative solutions to their problems.86 Increasingly, sex 
role research revealed that male patients, when they did seek medical 
help, tended to discuss the onset of somatic symptoms – often in rela-
tion to work stress. In such cases, psychotropic drugs alleviated inca-
pacitating symptoms, enabling them to continue work. Consistently in 
research, the most common symptoms related to chest palpitations and 
gastric symptoms. In rare studies that included combination prepara-
tions, the drug Librax emerged as commonly prescribed to men in such 
situations.87
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